| 1 |
Tejeda M, Gaal D, Hullan L, et al. Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models. Anticancer Res, 2006, 26(5A): 3477-3483.
|
| 2 |
Tsagarakis NJ, Drygiannakis I, Batistakis AG, et al. Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. World J Gastroenterol, 2011, 17(3): 313-321.
|
| 3 |
Ma Q, Meng LQ, Liu JC, et al. Octreotide induces apoptosis of human hepatoma cells by the mechanism of facilitating the Fas/FasL gene expression therein. Zhonghua Yi Xue Za Zhi, 2008, 88(10): 716-718.
|
| 4 |
李义生，王书奎，王和明, 等. 术前联合奥曲肽行淋巴化疗对大肠癌的治疗研究[J/CD]. 中华临床医师杂志:电子版, 2012, 6(11): 3121-3122.
|
| 5 |
Ferrante E, Pellegrini C, Bondioni S, et al. Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2. Endocr Relat Cancer, 2006, 13(3): 955-962.
|
| 6 |
Tagliati F, Zatelli MC, Bottoni A, et al. Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro. Endocrinology, 2006, 147(7): 3530-3538.
|
| 7 |
王松，包铮，龙建武, 等. APC/β-catenin/TCF通路在奥曲肽调控结肠癌SW480细胞中的分子机制. 世界华人消化杂志, 2010, 36(6): 3857-3862.
|
| 8 |
Chen JS, Liang QM, Long JW, et al. Octreotide inhibits growth of colonic cancer SW480cells by modulating the Wnt/β-catenin pathway. Pharmazie, 2009, 64(2): 126-131.
|
| 9 |
Lock FE, Underhill-Day N, Dunwell T, et al. The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways. Oncogene, 2010, 29(30):4307-4316.
|
| 10 |
Bikkavilli RK, Malbon CC. Mitogen-activated protein kinases and Wnt/β-catenin signaling: Molecular conversations among signaling pathways. Commun Integr Biol. 2009, 2(1): 46-49.
|
| 11 |
Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature, 2005, 434(7035): 843-850.
|
| 12 |
Meijer L, Flajoet M, Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci, 2004, 25(9): 471-480.
|
| 13 |
Parry JJ, Eiblmaier M, Andrews R, et al. Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells. Mol Imaging, 2007, 6(1): 56-67.
|
| 14 |
Siriwardana G, Bradford A, Coy D, et al. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol, 2006, 20(9): 2010-2019.
|
| 15 |
Theodoropoulou M, Zhang J, Laupheimer S, et al. Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zacl expression. Cancer Res, 2006, 66(3): 1576-1582.
|
| 16 |
Shi CS, Huang NN, Harrison K, et al. The mitogen-activated protein kinase kinase kinase kinase GCKR positively regulates canonical and noncanonical Wnt signaling in B lymphocytes. Mol Cell Biol, 2006, 26(17): 6511-6521.
|